Literature DB >> 16287683

Enteroviruses as agents of emerging infectious diseases.

G Palacios1, M S Oberste.   

Abstract

Although the enteroviruses as a group are ubiquitous and not normally considered as "emerging pathogens," the many different serotypes circulate at different frequencies in any given year and the prevalence of a given serotype may fluctuate wildly from year to year. As a result, several enterovirus serotypes have been associated with the emergence of specific diseases (for example, pandemic acute hemorrhagic conjunctivitis) and specific serotypes have emerged to cause outbreaks of major public health concern. Enterovirus 71 is a recognized cause of epidemic severe central nervous system disease in Southeast Asia. Acute hemorrhagic conjunctivitis was a newly described disease in the 1970s associated with emergence of enterovirus 70 and coxsackievirus A24 variant. In addition, the impending eradication of poliovirus and some of the challenges currently faced by the eradication program present the possibility that poliomyelitis could emerge in the posteradication era. These links between enterovirus infections and emerging diseases are reviewed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16287683     DOI: 10.1080/13550280591002531

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  111 in total

1.  Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1/2A(pro) cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes.

Authors:  M N Mulders; M Salminen; N Kalkkinen; T Hovi
Journal:  J Gen Virol       Date:  2000-03       Impact factor: 3.891

2.  Progress toward global eradication of poliomyelitis, January 2003-April 2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-06-25       Impact factor: 17.586

3.  Geographic distribution of wild poliovirus type 1 genotypes.

Authors:  R Rico-Hesse; M A Pallansch; B K Nottay; O M Kew
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

4.  Certification of the eradication of indigenous transmission of wild poliovirus in the Americas.

Authors:  F C Robbins; C A de Quadros
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

Review 5.  The group B coxsackieviruses and myocarditis.

Authors:  K S Kim; G Hufnagel; N M Chapman; S Tracy
Journal:  Rev Med Virol       Date:  2001 Nov-Dec       Impact factor: 6.989

Review 6.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

7.  Enterovirus etiology of the 1970 Singapore epidemic of acute conjunctivitis.

Authors:  R R Mirkovic; N J Schmidt; M Yin-Murphy; J L Melnick
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

8.  Molecular epidemiology of echovirus 30: temporal circulation and prevalence of single lineages.

Authors:  G Palacios; I Casas; D Cisterna; G Trallero; A Tenorio; C Freire
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

9.  Recombination in circulating enteroviruses.

Authors:  Alexander N Lukashev; Vasilii A Lashkevich; Olga E Ivanova; Galina A Koroleva; Ari E Hinkkanen; Jorma Ilonen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  A study of Coxsackie B virus infections, 1972-1983.

Authors:  E J Bell; R A McCartney
Journal:  J Hyg (Lond)       Date:  1984-10
View more
  74 in total

1.  Forecasting the economic value of an Enterovirus 71 (EV71) vaccine.

Authors:  Bruce Y Lee; Angela R Wateska; Rachel R Bailey; Julie H Y Tai; Kristina M Bacon; Kenneth J Smith
Journal:  Vaccine       Date:  2010-10-16       Impact factor: 3.641

2.  A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus.

Authors:  Jeffrey K Stone; Rene Rijnbrand; David A Stein; Yinghong Ma; Yan Yang; Patrick L Iversen; Raul Andino
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

3.  Detection of Enteroviruses in Influent and Effluent Flow Samples from Wastewater Treatment Plants in Italy.

Authors:  Andrea Battistone; Gabriele Buttinelli; Paolo Bonomo; Stefano Fiore; Concetta Amato; Pietro Mercurio; Antonella Cicala; Josef Simeoni; Adelheid Foppa; Maria Triassi; Francesca Pennino; Lucia Fiore
Journal:  Food Environ Virol       Date:  2013-11-26       Impact factor: 2.778

Review 4.  Virus infections as potential targets of preventive treatments for type 1 diabetes.

Authors:  Noora Nurminen; Sami Oikarinen; Heikki Hyöty
Journal:  Rev Diabet Stud       Date:  2012-12-28

5.  Simultaneous detection and differentiation of human rhino- and enteroviruses in clinical specimens by real-time PCR with locked nucleic Acid probes.

Authors:  Riikka Osterback; Tuire Tevaluoto; Tiina Ylinen; Ville Peltola; Petri Susi; Timo Hyypiä; Matti Waris
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

6.  Apoptosis of hippocampal pyramidal neurons is virus independent in a mouse model of acute neurovirulent picornavirus infection.

Authors:  Eric J Buenz; Brian M Sauer; Reghann G Lafrance-Corey; Chandra Deb; Aleksandar Denic; Christopher L German; Charles L Howe
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

7.  Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates.

Authors:  Si Ying Ho; Shi Qian Chua; Damian G W Foo; Camille Locht; Vincent T Chow; Chit Laa Poh; Sylvie Alonso
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

8.  Inferring nonneutral evolution from contrasting patterns of polymorphisms and divergences in different protein coding regions of enterovirus 71 circulating in Taiwan during 1998-2003.

Authors:  Hurng-Yi Wang; Kao-Chien Tsao; Chia-Hung Hsieh; Li-Min Huang; Tzou-Yien Lin; Guang-Wu Chen; Shin-Ru Shih; Luan-Yin Chang
Journal:  BMC Evol Biol       Date:  2010-09-25       Impact factor: 3.260

9.  Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany.

Authors:  Holger F Rabenau; Matthias Richter; Hans Wilhelm Doerr
Journal:  Med Microbiol Immunol       Date:  2009-11-26       Impact factor: 3.402

10.  Taipei's use of a multi-channel mass risk communication program to rapidly reverse an epidemic of highly communicable disease.

Authors:  Muh-Yong Yen; Tsung-Shu Joseph Wu; Allen Wen-Hsiang Chiu; Wing-Wai Wong; Po-En Wang; Ta-Chien Chan; Chwan-Chuen King
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.